Pharmala Biotech Holdings Inc C.MDMA

Alternate Symbol(s): MDXXF

PharmAla Biotech Holdings Inc. is a Canada-based biotechnology company. The Company is focused on the development, manufacture and sales of methylenedioxy methamphetamine (MDMA) and methylenedioxy phenethylamines (MDXX) class molecules in service to the burgeoning clinical research community and growing commercial use cases in select jurisdictions. The Company has three primary business lines: the manufacture of MDMA and MDXX class molecules for sale to clinical researchers in both the commercial and academic sphere, the research and development of novel MDXX class compounds which offer unique benefits above and beyond known substances, and the development of novel delivery mechanisms for MDMA and MDXX class compounds. Its research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. It works with laboratories across Canada to develop novel processes for the supply of LaNeo MDMA and other MDXX substances.

CSE:MDMA - Post by User

Pharmala Biotech Holdings Inc

<< Previous

Bullboard Posts

Next >>

Post by AjarnEvanon Mar 21, 2023 4:06pm

107 Views

Post# 35352092

This is a prime junior pharma biotech play

The big boys must be salivating at the potential of this company. How long until they can't ignore the indisputable competive advantage any longer. If a buyout happens I'm all for it but it seems like Pharmala has the means to go at it independently. Buy and hold.

<< Previous

Bullboard Posts

Next >>

Dollar Tree CEO Rick Dreiling steps down as discount retailer struggles